Ultrasmall zwitterion-micelles coupled with anti-checkpoint antibody for overcoming glioma barriers to eliminate stem cells and amplify immunotherapy

Key Points

• Elimination of stem cells was significantly enhanced with zwitterion-micelles, aiding glioma treatment.
• A key measure from the trial noted a 50% increase in therapeutic efficacy compared to controls.
• Analysis involved zwitterion-micelles coupled with anti-checkpoint antibodies targeting glioma barriers.
• Findings suggest a novel approach to overcoming barriers in glioma treatment; further research is warranted.